Suppr超能文献

急性注射镉金属硫蛋白并非研究慢性镉肾病的良好模型:大鼠慢性氯化镉和镉金属硫蛋白暴露与急性注射镉金属硫蛋白的比较。

Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.

作者信息

Liu J, Habeebu S S, Liu Y, Klaassen C D

机构信息

Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City 66160-7417, USA.

出版信息

Toxicol Appl Pharmacol. 1998 Nov;153(1):48-58. doi: 10.1006/taap.1998.8506.

Abstract

Kidney is the main target organ of Cd toxicity in humans. Cd-induced nephrotoxicity is thought to be caused by the Cd-metallothionein complex (CdMT) that "leaks" out of the liver and is taken up by the kidney. A single injection of CdMT has therefore been used as a model to study Cd nephropathy for the last 20 years. However, our recent studies reveal discrepancies between renal Cd concentration and nephrotoxic potencies of CdCl2 and CdMT. This study was further designed to critically evaluate whether a single injection of CdMT is an appropriate model to study the mechanism of chronic CdCl2 nephropathy. Age-matched rats were given multiple sc injections of either CdCl2 (0.8 and 1.2 mg Cd/kg) or CdMT (0.05 mg Cd/kg) daily, 6 days/week for 6 weeks, or a single injection of CdMT (0.2-0.6 mg Cd/kg i.p. for 24 h), and the nephrotoxicity was compared. Histologically, chronic CdCl2 or CdMT administration produced damage to the whole kidney, including tubular cell degeneration, apoptosis, and atrophy; interstitial inflammation; glomerular swelling; and sclerosis. In contrast, acute CdMT injection produced severe proximal tubule necrosis as the major feature of its toxicity. Biochemically, chronic exposure to Cd produced polyuria and calciuria, while proteinuria, glucosuria, and enzymuria were mild (2-5x). In contrast, acute CdMT nephrotoxicity was characterized by marked increases in urinary protein (13x), glucose (25x), N-acetyl-beta-d-glucosaminidase (28x), lactate dehydrogenase (100x), and gamma-glutamyltranspeptidase (160x). Serum levels of creatinine and blood urea nitrogen were unchanged following chronic Cd exposure but were markedly elevated (5x) after acute injection of CdMT. Chronic exposure to either CdCl2 or CdMT produced nephrotoxicity at renal Cd concentration of 85 to 110 micrograms/g kidney, while acute CdMT injection produced nephrotoxicity at only 5 to 7 micrograms/g kidney. In conclusion, the present study indicates that the features and mechanisms of renal injury from chronic Cd exposure are quite different from those produced by a single injection of CdMT. Therefore, it is proposed that acute CdMT injection is not an appropriate model for the study of chronic Cd-induced nephrotoxicity.

摘要

肾脏是镉对人类产生毒性作用的主要靶器官。镉诱导的肾毒性被认为是由从肝脏“泄漏”并被肾脏摄取的镉 - 金属硫蛋白复合物(CdMT)引起的。因此,在过去20年中,单次注射CdMT一直被用作研究镉肾病的模型。然而,我们最近的研究揭示了氯化镉(CdCl2)和CdMT的肾脏镉浓度与肾毒性效力之间存在差异。本研究进一步旨在严格评估单次注射CdMT是否是研究慢性CdCl2肾病机制的合适模型。将年龄匹配的大鼠每天多次皮下注射CdCl2(0.8和1.2 mg镉/ kg)或CdMT(0.05 mg镉/ kg),每周6天,共6周,或单次注射CdMT(0.2 - 0.6 mg镉/ kg腹腔注射24小时),并比较肾毒性。组织学上,慢性给予CdCl2或CdMT会对整个肾脏造成损伤,包括肾小管细胞变性、凋亡和萎缩;间质炎症;肾小球肿胀;以及硬化。相比之下,急性注射CdMT会导致严重的近端肾小管坏死,这是其毒性的主要特征。生化方面,慢性接触镉会导致多尿和钙尿,而蛋白尿、糖尿和酶尿则较轻(2 - 5倍)。相比之下,急性CdMT肾毒性的特征是尿蛋白(13倍)、葡萄糖(25倍)、N - 乙酰 - β - D - 氨基葡萄糖苷酶(28倍)、乳酸脱氢酶(100倍)和γ - 谷氨酰转肽酶(160倍)显著增加。慢性接触镉后血清肌酐和血尿素氮水平未发生变化,但急性注射CdMT后显著升高(5倍)。慢性接触CdCl2或CdMT在肾脏镉浓度为85至110微克/克肾脏时产生肾毒性,而急性注射CdMT仅在5至7微克/克肾脏时产生肾毒性。总之,本研究表明慢性接触镉引起的肾损伤特征和机制与单次注射CdMT所产生的有很大不同。因此,有人提出急性注射CdMT不是研究慢性镉诱导的肾毒性的合适模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验